Showing results (81-90 of 109) with videos related to
Sort By:
Pageof 11
Surgery|January 1, 1986
Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancerJ H Wong, C F Jackson, J S Swanson, et al.Investigational New Drugs|February 1, 1991
Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group studyJ A Kish, K Kopecky, M K Samson, et al.American Journal of Clinical Oncology|August 1, 1993
Evaluation of cisplatin and DTIC in inoperable stage III and IV melanoma. A Southwest Oncology Group studyW S Fletcher, D S Daniels, V K Sondak, et al.Cancer|February 15, 1984
Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma. A Southwest Oncology Group studyJ J Costanzi, W S Fletcher, S P Balcerzak, et al.Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.Journal of Surgical Oncology|January 1, 1976
A randomized pilot study comparing two regimens in the treatment of squamous cell carcinomaH S Moseley, T Sasaki, D B McConnell, et al.Journal of Surgical Oncology|January 1, 1979
5-FU versus combination therapy with tubercidin, streptozotocin, and 5-FU in the treatment of pancreatic carcinomas: COG protocol 7230A Awrich, W S Fletcher, J H Klotz, et al.Cancer|August 27, 1999
Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trialC G Leichman, J R Jacobson, M Modiano, et al.The American Journal of Gastroenterology|February 1, 1990
Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with SandostatinE J Mozell, E A Woltering, T M O'Dorisio, et al.Medical and Pediatric Oncology|January 1, 1988
VP-16 + adriamycin vs. adriamycin alone in advanced adenocarcinoma of the breast, phase II, a randomized trial: a Southwest Oncology Group StudyC B Vaughn, S J Green, R O'Bryan, et al.Pageof 11